Why the study?
Does bioprosthetic valve replacement improve survival or reduce complications compared to mechanical valve replacement in patients with end-stage renal disease?
Does bioprosthetic valve replacement improve survival or reduce complications compared to mechanical valve replacement in patients with end-stage renal disease?
In patients with end-stage renal disease requiring valve replacement, bioprosthetic valves offer similar survival to mechanical valves but with significantly lower risks of bleeding and thromboembolism.
No takes yet. Share an insight, caveat, or question.
Bioprosthetic valves may reduce bleeding and thromboembolism in ESRD without mortality difference; leaves open need for randomized confirmation.
Phan et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: